Perioperative Management of Antiplatelet-Drugs in Cardiac Surgery

被引：12

作者：

Ferrandis, Raquel ^{[1
]}

Llau, Juan V. ^{[1
]}

Mugarra, Ana ^{[1
]}

机构：

[1] Hosp Clin Univ, Dept Anaesthesiol & Crit Care Med, Valencia, Spain

来源：

CURRENT CARDIOLOGY REVIEWS | 2009年 / 5卷 / 02期

关键词：

D O I：

10.2174/157340309788166688

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The management of coronary patients scheduled for a coronary artery bypass grafting (CABG), who are receiving one or more antiplatelet drugs, is plenty of controversies. It has been shown that withdrawal of antiplatelet drugs is associated with an increased risk of a thrombotic event, but surgery under an altered platelet function also means an increased risk of bleeding in the perioperative period. Because of the conflict recommendations, this review article tries to evaluate the outcome of different perioperative antiplatelet protocols in patients with coronary artery disease undergoing CABG.

引用

页码：125 / 132

页数：8

共 84 条

[1] Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force [J].

Albaladejo, P. ;

Marret, E. ;

Piriou, V. ;

Samama, C. -M. .

BRITISH JOURNAL OF ANAESTHESIA, 2006, 97 (04) :580-582

[2] Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis [J].

Alghamdi, Abdullah A. ;

Moussa, Fuad ;

Fremes, Stephen E. .

JOURNAL OF CARDIAC SURGERY, 2007, 22 (03) :247-256

[3] Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass [J].

Andreasen, JJ ;

Nielsen, C .

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 26 (02) :311-317

[4]

Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71

[5] Is clopidogrel cardiovascular medicine's double-edged sword? [J].

Bavry, AA ;

Lincoff, AM .

CIRCULATION, 2006, 113 (13) :1638-1640

[6] Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment [J].

Beving, H ;

Zhao, C ;

Albage, A ;

Ivert, T .

BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (01) :80-84

[7] Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting [J].

Bizzarri, F ;

Scolletta, S ;

Tucci, E ;

Lucidi, M ;

Davoli, G ;

Toscano, T ;

Neri, E ;

Muzzi, L ;

Frati, G .

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 122 (06) :1181-1185

[8]

Bojar RM, 2005, MANUAL PERIOPERATIVE

[9] Low-dose aspirin for secondary cardiovascular prevention -: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation -: review and meta-analysis [J].

Burger, W ;

Chemnitius, JM ;

Kneissl, GD ;

Rücker, G .

JOURNAL OF INTERNAL MEDICINE, 2005, 257 (05) :399-414

[10] Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting [J].

Bybee, KA ;

Powell, BD ;

Valeti, U ;

Rosales, AG ;

Kopecky, SL ;

Mullany, C ;

Wright, S .

CIRCULATION, 2005, 112 (09) :I286-I292

← 1 2 3 4 5 6 7 8 9 →